Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

CUR

Neuralstem (CUR)

Neuralstem Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CUR
日付受信時刻ニュースソース見出しコード企業名
2021/03/2002 : 15GlobeNewswire Inc.NeuroRx Announces Dosing of First Patient with ZYESAMI™ in P2/3 Clinical Study for the Treatment of Moderate and Severe COV...NASDAQ:CURNeuralstem Inc
2020/09/0221 : 00PR Newswire (US)Letter from Seneca Biopharma's Executive ChairmanNASDAQ:CURNeuralstem Inc
2020/05/2800 : 00PR Newswire (US)Seneca Biopharma Announces the Closing of its $5 Million Registered Direct OfferingNASDAQ:CURNeuralstem Inc
2019/11/0506 : 18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
2019/11/0100 : 00PR Newswire (US)Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCANASDAQ:CURNeuralstem Inc
2019/10/3020 : 00PR Newswire (US)Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto...NASDAQ:CURNeuralstem Inc
2019/10/3019 : 22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
2019/10/2912 : 24PR Newswire (US)Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership SummitNASDAQ:CURNeuralstem Inc
2019/10/2822 : 00PR Newswire (US)Neuralstem Becomes Seneca BiopharmaNASDAQ:CURNeuralstem Inc
2019/10/1208 : 34Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CURNeuralstem Inc
2019/10/1208 : 32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:CURNeuralstem Inc
2019/10/1208 : 31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CURNeuralstem Inc
2019/10/1208 : 28Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CURNeuralstem Inc
2019/10/1208 : 26Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CURNeuralstem Inc
2019/10/1208 : 24Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CURNeuralstem Inc
2019/10/0322 : 31PR Newswire (US)Neuralstem Announces Adjustment to Inducement Grant Under Nasdaq Listing Rule 5636(c)(4)NASDAQ:CURNeuralstem Inc
2019/09/2505 : 52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
2019/09/2420 : 30PR Newswire (US)Neuralstem Announces Last Subject Enrolled in Phase 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Pat...NASDAQ:CURNeuralstem Inc
2019/09/1806 : 00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
2019/08/1503 : 32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
2019/08/1420 : 32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CURNeuralstem Inc
2019/08/1420 : 30PR Newswire (US)Neuralstem Reports Second Quarter 2019 Fiscal ResultsNASDAQ:CURNeuralstem Inc
2019/08/0922 : 05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CURNeuralstem Inc
2019/08/0722 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
2019/08/0720 : 30PR Newswire (US)Neuralstem Announces Nasdaq Hearings Panel Grants Request For Continued ListingNASDAQ:CURNeuralstem Inc
2019/07/3120 : 30PR Newswire (US)Neuralstem Closes $7.5 Million Underwritten Public OfferingNASDAQ:CURNeuralstem Inc
2019/07/3005 : 47Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:CURNeuralstem Inc
2019/07/2619 : 01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CURNeuralstem Inc
2019/07/2611 : 40PR Newswire (US)Neuralstem Announces Pricing of $7.5 Million Underwritten Public OfferingNASDAQ:CURNeuralstem Inc
2019/07/2519 : 05Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:CURNeuralstem Inc
 Showing the most relevant articles for your search:NASDAQ:CUR

最近閲覧した銘柄

Delayed Upgrade Clock